Clinical Trial Update: Prevalence of Enterobacteria With Decreased Susceptibility to Carbapenems in Eastern Inter- Region

View source ↗

Summary

A clinical trial update from CHU de Reims describes the prevalence of carbapenem-nonsusceptible Enterobacteriaceae in the Eastern Inter-Region, focusing on beta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carbapenem-resistant Enterobacteriaceae Infection

Snippet

Sponsor: CHU de Reims | Conditions: Infection With Beta-lactam Resistance in Enterobacteriaceae | Status: UNKNOWN